Year archive

Simcere Pharmaceutical Group Limited — 2024 filings

All 185 regulatory filings released by Simcere Pharmaceutical Group Limited (S2P) in 2024, sourced directly from the official regulator.

185 Filings

2024 Period

2024 filings (185)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2024-12-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-26	English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS Regulatory Filings	2024-12-23	English
FURTHER CHANGE IN USE OF PROCEEDS Capital/Financing Update	2024-12-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-04	English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF SANBEXIN SUBLINGUAL TABLETS IN CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-12-02	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-29	English
VOLUNTARY ANNOUNCEMENT - THE INCLUSION OF THREE INNOVATIVE DRUGS, COSELA, ENLITUO AND SANBEXIN, IN THE NEW NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2024-11-28	English
Next Day Disclosure Return Regulatory Filings	2024-11-22	English
Next Day Disclosure Return Regulatory Filings	2024-11-21	English
Next Day Disclosure Return Regulatory Filings	2024-11-19	English
Next Day Disclosure Return Regulatory Filings	2024-11-18	English
Next Day Disclosure Return Regulatory Filings	2024-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-04	English
Next Day Disclosure Return Regulatory Filings	2024-11-01	English
Next Day Disclosure Return Regulatory Filings	2024-10-31	English
Next Day Disclosure Return Regulatory Filings	2024-10-30	English
Next Day Disclosure Return Regulatory Filings	2024-10-29	English
Next Day Disclosure Return Regulatory Filings	2024-10-21	English
Next Day Disclosure Return Regulatory Filings	2024-10-18	English
Next Day Disclosure Return Regulatory Filings	2024-10-17	English
Next Day Disclosure Return Regulatory Filings	2024-10-16	English
Next Day Disclosure Return Regulatory Filings	2024-10-15	English
Next Day Disclosure Return Regulatory Filings	2024-10-14	English
Next Day Disclosure Return Regulatory Filings	2024-10-09	English
Next Day Disclosure Return Regulatory Filings	2024-10-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-04	English
Next Day Disclosure Return Regulatory Filings	2024-10-03	English
Next Day Disclosure Return Regulatory Filings	2024-09-27	English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF INTERIM REPORT 2024 Regulatory Filings	2024-09-27	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF INTERIM REPORT 2024 Regulatory Filings	2024-09-27	English
2024 INTERIM REPORT Regulatory Filings	2024-09-27	English
Next Day Disclosure Return Regulatory Filings	2024-09-26	English
Next Day Disclosure Return Regulatory Filings	2024-09-25	English
Next Day Disclosure Return Regulatory Filings	2024-09-23	English
Next Day Disclosure Return Regulatory Filings	2024-09-20	English
Next Day Disclosure Return Regulatory Filings	2024-09-19	English
Next Day Disclosure Return Regulatory Filings	2024-09-17	English
Next Day Disclosure Return Regulatory Filings	2024-09-16	English
Next Day Disclosure Return Regulatory Filings	2024-09-13	English
Next Day Disclosure Return Regulatory Filings	2024-09-12	English
Next Day Disclosure Return Regulatory Filings	2024-09-11	English
Next Day Disclosure Return Regulatory Filings	2024-09-10	English
Next Day Disclosure Return Regulatory Filings	2024-09-09	English
Next Day Disclosure Return Regulatory Filings	2024-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-05	English
Next Day Disclosure Return Regulatory Filings	2024-09-04	English
Next Day Disclosure Return Regulatory Filings	2024-09-03	English
Next Day Disclosure Return Regulatory Filings	2024-09-02	English
VOLUNTARY ANNOUNCEMENT - BREAKTHROUGH THERAPY DESIGNATION (BTD) OF SANBEXIN SUBLINGUAL TABLETS GRANTED BY THE U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2024-09-02	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO COOPERATION AGREEMENT WITH TARGETRX IN RELATION TO NON-SMALL CELL LUNG CANCER DRUG TGRX-326 Regulatory Filings	2024-09-02	English
Next Day Disclosure Return Regulatory Filings	2024-08-30	English
Next Day Disclosure Return Regulatory Filings	2024-08-29	English
Next Day Disclosure Return Regulatory Filings	2024-08-28	English
(Revised) Next Day Disclosure Return Regulatory Filings	2024-08-28	English
Next Day Disclosure Return Regulatory Filings	2024-08-27	English
Next Day Disclosure Return Regulatory Filings	2024-08-26	English
Next Day Disclosure Return Regulatory Filings	2024-08-23	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0508 (PolQ SMALL MOLECULE INHIBITOR) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-08-22	English
GRANT OF AWARDS UNDER THE 2021 RSU SCHEME Regulatory Filings	2024-08-22	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 Regulatory Filings	2024-08-21	English
Next Day Disclosure Return Regulatory Filings	2024-08-19	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-05	English
RESULTS ESTIMATE Regulatory Filings	2024-07-30	English
Next Day Disclosure Return Regulatory Filings	2024-07-19	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION (NDA) OF QUVIVIQ (DARIDOREXANT HYDROCHLORIDE TABLETS) HAS BEEN ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-07-16	English
Next Day Disclosure Return Regulatory Filings	2024-07-15	English
Next Day Disclosure Return Regulatory Filings	2024-07-11	English
VOLUNTARY ANNOUNCEMENT - REGULAR APPROVAL OF XIANNUOXIN, AN ANTI-SARS-COV-2 INNOVATIVE DRUG APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA Regulatory Filings	2024-07-11	English
Next Day Disclosure Return Regulatory Filings	2024-07-10	English
Next Day Disclosure Return Regulatory Filings	2024-07-09	English
Next Day Disclosure Return Regulatory Filings	2024-07-08	English
Next Day Disclosure Return Regulatory Filings	2024-07-05	English
Next Day Disclosure Return Regulatory Filings	2024-07-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-03	English
Next Day Disclosure Return Regulatory Filings	2024-07-03	English
Next Day Disclosure Return Regulatory Filings	2024-07-02	English
Next Day Disclosure Return Regulatory Filings	2024-06-28	English
Next Day Disclosure Return Regulatory Filings	2024-06-27	English
Next Day Disclosure Return Regulatory Filings	2024-06-26	English
VOLUNTARY ANNOUNCEMENT - APPROVAL ON THE MARKETING OF ENLITUO (CETUXIMAB BETA INJECTION) IN CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-06-25	English
Next Day Disclosure Return Regulatory Filings	2024-06-25	English
Next Day Disclosure Return Regulatory Filings	2024-06-24	English
Next Day Disclosure Return Regulatory Filings	2024-06-20	English
Next Day Disclosure Return Regulatory Filings	2024-06-18	English
CHANGE OF JOINT COMPANY SECRETARY AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES Regulatory Filings	2024-06-14	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Regulatory Filings	2024-06-14	English
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-06-14	English
(I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 14, 2024 AND (II) PAYMENT OF FINAL DIVIDEND Regulatory Filings	2024-06-14	English
Next Day Disclosure Return Regulatory Filings	2024-06-13	English
Next Day Disclosure Return Regulatory Filings	2024-06-12	English
Next Day Disclosure Return Regulatory Filings	2024-06-11	English
Next Day Disclosure Return Regulatory Filings	2024-06-07	English
Next Day Disclosure Return Regulatory Filings	2024-06-06	English
Next Day Disclosure Return Regulatory Filings	2024-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-05	English
VOLUNTARY ANNOUNCEMENT - RESULTS OF THE PHASE III CLINICAL TRIAL OF ENZESHU (SUVEMCITUG FOR INJECTION) FOR THE TREATMENT OF PLATINUM-RESISTANT OVARIAN CANCER WERE PRESENTED AT THE ASCO ANNUAL MEETING Regulatory Filings	2024-06-03	English
Next Day Disclosure Return Regulatory Filings	2024-05-31	English
VOLUNTARY ANNOUNCEMENT - THE PHASE III CLINICAL STUDY OF DARIDOREXANT HYDROCHLORIDE TABLETS IN THE TREATMENT OF INSOMNIA PATIENTS IN CHINA HAS MET THE PRIMARY ENDPOINT Regulatory Filings	2024-05-31	English
Next Day Disclosure Return Regulatory Filings	2024-05-30	English
Next Day Disclosure Return Regulatory Filings	2024-05-29	English
Next Day Disclosure Return Regulatory Filings	2024-05-28	English
Next Day Disclosure Return Regulatory Filings	2024-05-27	English
Next Day Disclosure Return Regulatory Filings	2024-05-24	English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-05-23	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM Regulatory Filings	2024-05-23	English
PROXY FORM FOR ANNUAL GENERAL MEETING Regulatory Filings	2024-05-23	English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND; A Regulatory Filings	2024-05-23	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-05-23	English
VOLUNTARY ANNOUNCEMENT - THE HYPNOTICS DARIDOREXANT HYDROCHLORIDE TABLETS OBTAINED THE CERTIFICATE OF DRUG/ PRODUCT REGISTRATION ISSUED BY THE PHARMACY AND POISONS BOARD OF HONG KONG Regulatory Filings	2024-05-22	English
Next Day Disclosure Return Regulatory Filings	2024-05-21	English
Next Day Disclosure Return Regulatory Filings	2024-05-20	English
Next Day Disclosure Return Regulatory Filings	2024-05-17	English
Next Day Disclosure Return Regulatory Filings	2024-05-16	English
Next Day Disclosure Return Regulatory Filings	2024-05-14	English
Next Day Disclosure Return Regulatory Filings	2024-05-13	English
Next Day Disclosure Return Regulatory Filings	2024-05-10	English
Next Day Disclosure Return Regulatory Filings	2024-05-09	English
Next Day Disclosure Return Regulatory Filings	2024-05-08	English
Next Day Disclosure Return Regulatory Filings	2024-05-07	English
Next Day Disclosure Return Regulatory Filings	2024-05-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
Next Day Disclosure Return Regulatory Filings	2024-05-03	English
Next Day Disclosure Return Regulatory Filings	2024-04-30	English
Next Day Disclosure Return Regulatory Filings	2024-04-29	English
Next Day Disclosure Return Regulatory Filings	2024-04-25	English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2023 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2024-04-24	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2023 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2024-04-24	English
2023 ANNUAL REPORT Regulatory Filings	2024-04-24	English
2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2024-04-24	English
Next Day Disclosure Return Regulatory Filings	2024-04-24	English
Next Day Disclosure Return Regulatory Filings	2024-04-23	English
Next Day Disclosure Return Regulatory Filings	2024-04-22	English
Next Day Disclosure Return Regulatory Filings	2024-04-21	English
Next Day Disclosure Return Regulatory Filings	2024-04-18	English
Next Day Disclosure Return Regulatory Filings	2024-04-17	English
Next Day Disclosure Return Regulatory Filings	2024-04-16	English
Next Day Disclosure Return Regulatory Filings	2024-04-15	English
Next Day Disclosure Return Regulatory Filings	2024-04-12	English
Next Day Disclosure Return Regulatory Filings	2024-04-10	English
VOLUNTARY ANNOUNCEMENT - SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) WAS GRANTED U.S. FDA FAST TRACK DESIGNATION Regulatory Filings	2024-04-09	English
Next Day Disclosure Return Regulatory Filings	2024-04-09	English
Next Day Disclosure Return Regulatory Filings	2024-04-08	English
Next Day Disclosure Return Regulatory Filings	2024-04-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-05	English
Next Day Disclosure Return Regulatory Filings	2024-04-03	English
Next Day Disclosure Return Regulatory Filings	2024-04-02	English
Next Day Disclosure Return Regulatory Filings	2024-03-28	English
Next Day Disclosure Return Regulatory Filings	2024-03-27	English
Next Day Disclosure Return Regulatory Filings	2024-03-26	English
Next Day Disclosure Return Regulatory Filings	2024-03-25	English
Next Day Disclosure Return Regulatory Filings	2024-03-22	English
Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-03-21	English
Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-03-21	English
ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS Regulatory Filings	2024-03-21	English
GRANT OF AWARDS UNDER THE 2021 RSU SCHEME Regulatory Filings	2024-03-21	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Regulatory Filings	2024-03-20	English
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-03-20	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-03-20	English
ADOPTION OF EQUITY INCENTIVE SCHEME BY SIMCERE ZAIMING AND CONNECTED TRANSACTION IN RELATION TO CAPITAL CONTRIBUTIONS IN SIMCERE ZAIMING Regulatory Filings	2024-03-20	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF SUVEMCITUG FOR INJECTION ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-03-15	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-03-12	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE INVESTIGATIONAL NEW DRUG FOR SIM0500 (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2024-03-10	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-05	English
DISCLOSEABLE TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN SIMCERE ZAIMING Regulatory Filings	2024-02-25	English
VOLUNTARY ANNOUNCEMENT - PUBLICATION BY JAMA NEUROLOGY ABOUT THE PHASE III CLINICAL STUDIES RESULTS OF SANBEXIN SUBLINGUAL TABLETS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE Regulatory Filings	2024-02-20	English
PROFIT ALERT Regulatory Filings	2024-02-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-06	English
Next Day Disclosure Return Regulatory Filings	2024-02-05	English
Next Day Disclosure Return Regulatory Filings	2024-01-19	English
VOLUNTARY ANNOUNCEMENT - PUBLICATION BY THE NEW ENGLAND JOURNAL OF MEDICINE ABOUT THE PHASE II/III CLINICAL STUDIES RESULTS OF XIANNUOXIN, AN ANTI-SARS-COV-2 INNOVATIVE DRUG, FOR THE TREATMENT OF Regulatory Filings	2024-01-18	English
Next Day Disclosure Return Regulatory Filings	2024-01-18	English
FURTHER ANNOUNCEMENT ON THE CONTINUING CONNECTED TRANSACTION UNDER THE EXCLUSIVE PROMOTION SERVICES COOPERATION AGREEMENT Regulatory Filings	2024-01-17	English
Next Day Disclosure Return Regulatory Filings	2024-01-17	English
Next Day Disclosure Return Regulatory Filings	2024-01-16	English
Next Day Disclosure Return Regulatory Filings	2024-01-15	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0501 TABLETS (AN USP1 SMALL-MOLECULE INHIBITOR) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-01-12	English
Next Day Disclosure Return Regulatory Filings	2024-01-12	English
Next Day Disclosure Return Regulatory Filings	2024-01-08	English
VOLUNTARY ANNOUNCEMENT - THE PHASE III CLINICAL STUDY OF SUVEMCITUG FOR INJECTION IN THE TREATMENT OF PLATINUM-RESISTANT OVARIAN CANCER HAS SUCCESSFULLY MET THE PRIMARY STUDY ENDPOINT Regulatory Filings	2024-01-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-03	English
Next Day Disclosure Return Regulatory Filings	2024-01-02	English
CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF ENTIRE EQUITY INTEREST IN THE TARGET COMPANY Regulatory Filings	2024-01-01	English